1. A multi-centre study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of docetaxel-cyclophosphamide induced febrile neutropenia. (August 2021) Authors: Clemons, Mark; Fergusson, Dean; Joy, Anil A.; Thavorn, Kednapa; Meza-Junco, Judith; Hiller, Julie Price; Mackey, John; Ng, Terry; Zhu, Xiaofu; Ibrahim, Mohammed F.K.; Sienkiewicz, Marta; Saunders, Deanna; Vandermeer, Lisa; Pond, Gregory; Basulaiman, Bassam; Awan, Arif; Pitre, Lacey; Nixon, Nancy ... Journal: Breast Issue: Volume 58(2021) Page Start: 42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer. (January 2021) Authors: Clemons, Mark; Ong, Michael; Stober, Carol; Ernst, Scott; Booth, Christopher; Canil, Christina; Mates, Mihaela; Robinson, Andrew; Blanchette, Phillip; Joy, Anil Abraham; Hilton, John; Aseyev, Olexiy; Pond, Gregory; Jeong, Ahwon; Hutton, Brian; Mazzarello, Sasha; Vandermeer, Lisa; Kushnir, Igal; F... Journal: European journal of cancer Issue: Volume 142(2021) Page Start: 132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adjuvant trastuzumab for breast cancer. Issue 7524 (3rd November 2005) Authors: Dent, Rebecca; Clemons, Mark Journal: BMJ Issue: Volume 331:Issue 7524(2005) Page Start: 1035 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Amenorrhoea, menopause, and endocrine therapy for breast cancer. (3rd December 2009) Authors: Amir, Eitan; Seruga, Bostjan; Freedman, Orit; Clemons, Mark Journal: BMJ Issue: Volume 339(2009) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Attitudes towards open‐label versus placebo‐control designs in oncology randomized trials: A survey of medical oncologists. Issue 3 (21st February 2022) Authors: Kushnir, Igal; Clemons, Mark; Fergusson, Dean; Bossé, Dominick; Reaume, Martin Neil Journal: Journal of evaluation in clinical practice Issue: Volume 28:Issue 3(2022) Page Start: 495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Bone-targeted therapy use in patients with bone metastases from lung cancer: A systematic review of randomized controlled trials. (November 2016) Authors: LeVasseur, Nathalie; Clemons, Mark; Hutton, Brian; Shorr, Risa; Jacobs, Carmel Journal: Cancer treatment reviews Issue: Volume 50(2016) Page Start: 183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Breast cancer in Indigenous women living in Canada: a scoping review protocol. Issue 12 (23rd December 2021) Authors: Cole, Katherine Marie; Hutton, Brian; Hamel, Candyce; Bourque, Jean-Marc; Arnaout, Angel; Clemons, Mark Journal: JBI evidence synthesis Issue: Volume 19:Issue 12(2021:Dec.) Page Start: 3412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2. (November 2018) Authors: Campone, Mario; Im, Seock-Ah; Iwata, Hiroji; Clemons, Mark; Ito, Yoshinori; Awada, Ahmad; Chia, Stephen; Jagiełło-Gruszfeld, Agnieszka; Pistilli, Barbara; Tseng, Ling-Ming; Hurvitz, Sara; Masuda, Norikazu; Cortés, Javier; De Laurentiis, Michele; Arteaga, Carlos L.; Jiang, Zefei; Jonat, Walter; Le... Journal: European journal of cancer Issue: Volume 103(2018) Page Start: 147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 7 (July 2017) Authors: Baselga, José; Im, Seock-Ah; Iwata, Hiroji; Cortés, Javier; De Laurentiis, Michele; Jiang, Zefei; Arteaga, Carlos L; Jonat, Walter; Clemons, Mark; Ito, Yoshinori; Awada, Ahmad; Chia, Stephen; Jagiełło-Gruszfeld, Agnieszka; Pistilli, Barbara; Tseng, Ling-Ming; Hurvitz, Sara; Masuda, Norikazu; Taka... Journal: Lancet oncology Issue: Volume 18:Issue 7(2017:Jul.) Page Start: 904 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Chemotherapy in the oldest old: The feasibility of delivering cytotoxic therapy to patients 80 years old and older. Issue 5 (September 2015) Authors: Sud, Shelly; Lai, Pamela; Zhang, Tinghua; Clemons, Mark; Wheatley-Price, Paul Journal: Journal of geriatric oncology Issue: Volume 6:Issue 5(2015) Page Start: 395 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗